The emerging role of miR-506 in cancer

Abstract

// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Jian Li1, Jingfang Ju2, Bing Ni3 and Huaizhi Wang1 1 Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing, PR China 2 Translational Research Laboratory, Department of Pathology, Stony Brook University, Stony Brook, NY, USA 3 Department of Pathophysiology and High Altitude Pathology, Third Military Medical University, Chongqing, PR China Correspondence to: Huaizhi Wang, email: // <![CDATA[ mail("whuaizhi","gmail",0,"") // ]]> Bing Ni, email: // <![CDATA[ mail("nibingxi","126",0,"") // ]]> Jingfang Ju, email: // <![CDATA[ mail("jingfang.ju","stonybrookmedicine",14,"") // ]]> Keywords: microRNAs; miR-506; cancer; tumor suppressor Received: April 06, 2016 Accepted: August 10, 2016 Published: August 15, 2016